Načítá se...
Chelation for autism spectrum disorder (ASD)
BACKGROUND: It has been suggested that the severity of autism spectrum disorder (ASD) symptoms is positively correlated with the level of circulating or stored toxic metals, and that excretion of these heavy metals, brought about by the use of pharmaceutical chelating agents, results in improved sym...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2015
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457964/ https://ncbi.nlm.nih.gov/pubmed/26114777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010766.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|